Moffitt at AACR

A researcher at Moffitt

Every year the American Association for Cancer Research (AACR) brings scientists, clinicians and other health care professionals together to share the latest advances in cancer science and medicine. This year Moffitt is proud to once again bring our latest science to the annual meeting. Our scientists, clinicians and researchers will be sharing advancements in evolutionary therapy, targeted therapies, healthcare disparities and more for several cancer types.

For a complete list of Moffitt abstracts check out our Virtual Program.

Moffitt at AACR Virtual Program

Interested in talking to us one on one? Stop by our booth #305 and learn more about the impact Moffitt is making in cancer research. Recruiters will also be on site if you’re interested in learning more about our postdoctoral training.

To learn more about Moffitt’s research and breakthroughs, follow Moffitt on Twitter @MoffittNews and LinkedIn.

Features from 2023

Are HIV Patients Undertreated for Cancer?
Moffitt investigates the potential for interactions between antiretroviral therapy and chemotherapy.

Navigating Racial and Ethnic Criteria Appropriately Could Boost Clinical Trial Eligibility
According to researchers, criteria may pose additional barriers to minority cancer patients

Global Clinical Trial Explores New Combination Therapy for Metastatic Breast Cancer
The ongoing VIKTORIA-1 Phase 3 trial targets patients with hormone receptor positive, HER2 negative breast cancer

Media Contact:

For additional information on Moffitt’s research presented at AACR please reach out to:

Photo of Kim Polacek
Kim Polacek, APR, CPRC
Senior PR Account Coordinator
Email

2023 Video Features

Full 2023 Video Playlist

Congratulations to Moffitt’s NextGen Award Recipient!

Doratha Byrd, PhD, MPH
A biobank of Fecal Immunochemical Tests (FIT) for gut microbiome measurement: A paradigm for studying the microbiome and cancer
Major Symposium SY22
Microbiome and Cancer Immunotherapy